Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.
about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialStrengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience.Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II studyINSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerQuantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerMaintenance treatment with chemotherapy and immunotherapy in non-small cell lung cancer: a case report.Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposureEnhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors.Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance.
P2860
Q21261279-E36CBC40-06A5-4DF3-9D04-D0BD54104514Q31050197-2ED8432F-83D0-497B-9835-819FD48530D5Q33403648-F175E189-D446-4728-95E2-DB48BD863318Q33779303-D550595F-EB1F-42AA-B5AA-49CAB014746FQ34044082-45021E75-2B8A-4B2B-B68E-7543AD9D117FQ35078470-631000BC-E795-45CF-9D40-8BD41647A818Q37975010-526BF591-B2AA-402E-AAB6-457CEF8DA89AQ38056730-47A39B06-13C5-4263-BCDB-284214AF6AA2Q39188252-F2433B44-AC3B-4B37-9B93-4252C6800559Q39340865-3254A794-53C1-4FFB-8B27-E5DAE12DB208Q50050377-93FEFEF2-8BE0-4D24-A1C1-E99B0527C163Q53701964-00476ECF-A162-4E2B-B903-6B0828A83A76Q54282316-AC2C8D84-890E-4E6A-B712-C46D6119C7F3
P2860
Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maintenance and consolidation ...... IV non-small cell lung cancer.
@en
Maintenance and consolidation ...... IV non-small cell lung cancer.
@nl
type
label
Maintenance and consolidation ...... IV non-small cell lung cancer.
@en
Maintenance and consolidation ...... IV non-small cell lung cancer.
@nl
prefLabel
Maintenance and consolidation ...... IV non-small cell lung cancer.
@en
Maintenance and consolidation ...... IV non-small cell lung cancer.
@nl
P2860
P921
P1433
P1476
Maintenance and consolidation ...... IV non-small cell lung cancer.
@en
P2093
Jim Heighway
Nicholas Thatcher
P2860
P304
P356
10.1634/THEONCOLOGIST.2009-0292
P577
2010-10-07T00:00:00Z